WO2020133361A1 - Kit de soins de la peau - Google Patents

Kit de soins de la peau Download PDF

Info

Publication number
WO2020133361A1
WO2020133361A1 PCT/CN2018/125363 CN2018125363W WO2020133361A1 WO 2020133361 A1 WO2020133361 A1 WO 2020133361A1 CN 2018125363 W CN2018125363 W CN 2018125363W WO 2020133361 A1 WO2020133361 A1 WO 2020133361A1
Authority
WO
WIPO (PCT)
Prior art keywords
composition
weight
kit according
polyvalent metal
water soluble
Prior art date
Application number
PCT/CN2018/125363
Other languages
English (en)
Inventor
Lingwei XU
Yuhua YE
Original Assignee
L'oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by L'oreal filed Critical L'oreal
Priority to CN202210758396.0A priority Critical patent/CN115192473B/zh
Priority to PCT/CN2018/125363 priority patent/WO2020133361A1/fr
Priority to CN201880100560.0A priority patent/CN113194908B/zh
Publication of WO2020133361A1 publication Critical patent/WO2020133361A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/733—Alginic acid; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0212—Face masks
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/23—Sulfur; Selenium; Tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/731—Cellulose; Quaternized cellulose derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8152—Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/88—Two- or multipart kits
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/88—Two- or multipart kits
    • A61K2800/882—Mixing prior to application

Definitions

  • the present invention relates to an alginic system, especially to an alginic kit caring for the skin. Further, the present invention relates to use of same, especially as a mask for caring for keratin materials, especially the skin.
  • compositions for caring for keratin materials in particular the skin
  • masks are known to have high penetration efficacy on the keratin materials.
  • a two-digit market growth of mask cosmetic products in China was seen.
  • paste type and peel-off type masks are mainly used for cleansing of the keratin materials, whereas gel type and wet tissue type masks are more often used for caring for the skin.
  • gel type masks having good adhesion to the skin and can provide good fresh feel, however, may be insufficient in delivering moisturizing or hydration effect to the skin, while a wet issue type mask is good at delivering moisturizing and hydration effect, but will take it back if applied for an elongated period of time.
  • the adhesion with the skin may not be as good as the gel type masks.
  • the mask to be applied on face is soft, bringing better touch feeling and better fitness to the skin.
  • masks which is capable of texture transformation, for example, from tissue to gel, creating a pleasant consumer experience.
  • masks which have a moisture or actives delivery capacity that is at least on par with or even greater than that observed with wet tissue type masks.
  • masks which can deliver moisturizing effect or actives to keratin materials for an elongated period of time and does not take it back, whereby exhibiting further improved e.g. hydration effect as compared with wet tissue type masks.
  • the present inventors discovered that the conception or gist of the present invention is applicable not only to the cosmetic field, but also to other fields like the medical field, then the masks of the preceding aspects may be broadened to kits, which show the benefits described herein in connection with these masks as well.
  • the present inventors have discovered that a specific combination of 1) a first composition comprising at least one water insoluble salt of polyvalent metal, as an ion donator of the polyvalent metal, and at least one water soluble polyhydroxy polymer; and 2) a second composition comprising at least one aqueous phase, and a) optionally, at least one water soluble chelating agent of the polyvalent metal ion, and b) at least one water soluble gelatinizing agent, which is gelatinizable with the polyvalent metal ion may satisfy one or more of the abovementioned requirements.
  • One subject of the invention is thus to provide a kit comprising the first composition and the second composition separately placed from one another.
  • a mask package 1 comprising: 1) a first composition comprising at least one water insoluble salt of polyvalent metal, at least one fiber rich in hydroxy groups, and at least one water soluble polyhydroxy polymer, and 2) a fourth composition comprising at least one aqueous phase, and, b) at least one water soluble gelatinizing agent, which is gelatinizable with the polyvalent metal ion; wherein the first composition and the fourth composition are separately placed from one another.
  • Another subject of the present invention is use of the second composition as juice or a part of juice for mask product, wherein the mask product comprises, separate from the second composition, a fabric (or tissue) comprising at least one water insoluble salt of polyvalent metal according to the invention.
  • kits according to the present invention for caring for keratin materials, especially the skin.
  • This use may manifest itself as a process for caring for keratin materials, especially the skin, comprising the steps of compounding the first composition and the second composition of the kit at a predetermined weight ratio, and then applying to said keratin materials the thus obtained mixture.
  • kits according to the present invention for managing skin wound, for preventing post-surgical adhesion formation, or for filling or repairing osteochondral defects, and so on.
  • This use may manifest itself as a process for managing skin wound, for preventing post-surgical adhesion formation, or for filling or repairing osteochondral defects, comprising the steps of compounding the first composition and the second composition of the kit at a predetermined weight ratio, and then applying to a location in need of the thus obtained mixture.
  • the “keratin material” is the skin.
  • skin we intend all the body skin.
  • the keratin material is the face, or the neck, especially the face.
  • topical application it meant that the composition is applied or spread onto the surface of the keratin materials, such as at least one zone of the skin.
  • rinse off it is meant a composition which after being applied on the skin for a predetermined period of time, is removed from the skin by a rinsing composition such as water.
  • alkali metal refers to an element located in Group IA of the periodic table, such as sodium, potassium, lithium or a combination thereof, preferably sodium, potassium or a combination thereof.
  • water-soluble or water-dispersible means a compound which, when introduced into water at 25°C, at a mass concentration equal to 1%, make it possible to obtain a macroscopically homogeneous and transparent solution, i.e. a solution with a maximum light transmittance value, at a wavelength equal to 500 nm, through a sample 1 cm thick, of at least 60%and preferably of at least 70%.
  • the kit comprises a first composition and a second composition.
  • the first composition according to the present invention comprises at least one water insoluble salt of polyvalent metal and at least one water soluble polyhydroxy polymer.
  • water insoluble means that the salt is not dissolvable, e.g., having a solubility of less than 0.01g/100g of water or only slightly soluble, e.g., having a solubility of less than 0.5g/100g of water, in water, nor does it break apart in the bulk state upon immersion in water.
  • the at least one water insoluble salt of polyvalent metal may be present in form of powder, particulate, fiber or bulk state.
  • the term "particulate" when being used for the water insoluble salt of polyvalent metal, means that the salt is in the form of particles.
  • water insoluble salt of polyvalent metal may be formed from an acid anion and a polyvalent metal cation, especially calcium, strontium, zinc, copper, manganese, aluminum, or mixtures thereof.
  • the useful metal is preferably calcium, copper or a mixture thereof, more preferably calcium.
  • the acid to provide acid anion according to the present invention can be any known acid useful in cosmetic products, provided that the salt formed from the acid with the polyvalent metal is water insoluble or slightly soluble.
  • the typical acids may be used comprise various inorganic acids, e.g., sulphate, carbonic acid, phosphoric acid meta-aluminic acid, silicic acid, and various organic acids, especially higher saturated or unsaturated fatty acids, in particular those having 18 or more carbon atoms, e.g., stearic acid and oleic acid, or polycarboxylic acids, especially e.g., alginic acid, oxalic acid, as long as the salt formed is water insoluble or slightly soluble.
  • the at least one water insoluble salt of polyvalent metal may be a sulphate or alginate, preferably chosen from calcium sulphate/alginate, strontium sulphate/alginate, zinc sulphate/alginate, copper sulphate/alginate, manganese sulphate/alginate, or a mixture thereof, preferably calcium sulphate/alginate or copper sulphate/alginate, in particular calcium sulphate/alginate.
  • alginate in particular means a salt of alginic acid.
  • Alginic acid a natural substance obtained from brown algae or from certain bacteria, is a polyuronic acid composed of two uronic acids linked together via 1, 4-glycoside bonds: ⁇ -D-mannuronic acid (M) and ⁇ -L-glucuronic acid (G) .
  • Water insoluble alginates in which the principal cation is calcium, are specifically found in the fronds and stems of seaweeds of the class Phaeophyceae, examples of which are Fucus vesiculosus, Fucus spiralis, Ascophyllum nodosum, Macrocystis pyrifera, Alaria esculenta, Eclonia maxima, Lessonia nigrescens, Lessonia trabeculata, Laminaria japonica, Durvillea antarctica, Laminaria hyperborea, Laminaria longicruris, Laminaria digitata, Laminaria saccharina, Laminaria cloustoni, and Saragassum sp.
  • Suitable water insoluble alginates have a weight-average molecular weight of about 20,000 Daltons to about 500,000 Daltons.
  • the weight-average molecular weight is calculated by first determining the intrinsic viscosity, then using the Mark-Houwink Sakurada Equation, as in Martinsen, et al, "Comparison of Different Methods for Determination of Molecular Weights and Molecular Weight Distribution of Alginates” (Carbohydr. Polym., 15, 171-193, 1991) .
  • polyhydroxy polymer means a hydroxy-containing nonionic polysaccharide.
  • fiber rich in hydroxy groups means a fiber having at least 2 hydroxy groups, preferably at least 3 hydroxy groups, per repeating unit of the polymer of the fiber and having at least one hydroxy-containing side chain, wherein less than 60%, preferably less than 30%, or preferably less than 15%, of hydroxy groups in the side chains are substituted.
  • Useful water soluble polyhydroxy polymers comprise polyhydroxycarboxylic acids, esters of the acids; polyhydroxy celluloses; and the like.
  • Some celluloses are known to be useful for promoting gelling behavior. Accordingly, polyhydroxy celluloses are preferably useful.
  • nonionic polyhydroxy cellulose ethers are specially preferable, in which mention may be made of hydroxyalkylcelluloses such as hydroxymethylcelluloses, hydroxyethylcelluloses (HEC) and hydroxypropylcelluloses (HPC) ; and mixed hydroxyalkylalkylcelluloses such as hydroxy propylmethylcelluloses, hydroxy ethylmethylcelluloses, hydroxy ethylethylcelluloses and hydroxybutylmethylcelluloses.
  • hydroxyalkylcelluloses such as hydroxymethylcelluloses, hydroxyethylcelluloses (HEC) and hydroxypropylcelluloses (HPC)
  • HEC hydroxypropylcelluloses
  • mixed hydroxyalkylalkylcelluloses such as hydroxy propylmethylcelluloses, hydroxy ethylmethylcelluloses, hydroxy ethylethylcelluloses and hydroxybutylmethylcelluloses.
  • the first composition of the present invention may comprise the at least one water soluble polyhydroxy polymer in a content ranging from 0.001%to 1%by weight, especially from 0.01%to 0.1%by weight, such as 0.01%to 0.06%, relative to the total weight of the first composition.
  • the first composition may comprise at least one superabsorbent material.
  • the at least one superabsorbent material may be present in form of powder, particulate, fiber or bulk state.
  • the superabsorbent material advantageously presents very great ability to absorb a liquid, and in particular water. In particular, it may present the capacity to absorb 15 times, or even 20 times to 50 times its own weight in water, e.g. about 25 times to 30 times.
  • the capacity of the superabsorbent material for absorbing liquid can be determined by implementing the following method.
  • M D dry state
  • the superabs orbent material is obtained in the "dry" state by being treated in a drying oven for about 4 hours (h) at about 50°C.
  • Water (or any other liquid that is to be absorbed by the material) is put into contact with the material. This can be done either by immersing the material in the liquid, or else by pouring the liquid onto the material. For example, the material may be immersed for a duration of about 1 minute (min) .
  • the quantity of water (or liquid) is used in excess so as to saturate the material completely, for example.
  • the excess water (or liquid) is then eliminated, e.g. by drip-drying for about 2 min, and the material saturated in liquid is weighed (M L ) .
  • the difference ⁇ between the weight of the material when saturated in liquid and the weight of the material when dry represents the quantity of liquid that it has absorbed, which weight is compared with the dry weight of the material.
  • the resulting value C is indicative of the capacity of the superabsorbent material to absorb the liquid, e.g. expressed in grams of liquid absorbed per gram of dry material:
  • the superabsorbent material may be selected from cellulose derivatives, alginates (not including the water insoluble alginates and the alkali metal alginic compounds described herein as the water soluble gelatinizing agent) and derivatives thereof, in particular derivatives such as propylene glycol alginate, or salts thereof, derivatives of polyacrylic acid or polymethacrylic acid, derivatives of poly (meth) acrylamide, derivatives of polyvinylpyrrolidone, derivatives of poly-vinyl ether, and mixtures thereof, amongst others.
  • alginates not including the water insoluble alginates and the alkali metal alginic compounds described herein as the water soluble gelatinizing agent
  • derivatives thereof in particular derivatives such as propylene glycol alginate, or salts thereof, derivatives of polyacrylic acid or polymethacrylic acid, derivatives of poly (meth) acrylamide, derivatives of polyvinylpyrrolidone, derivatives of poly-vinyl ether, and mixture
  • the superabsorbent material may be selected from derivatives of chemically modified cellulose.
  • it may be selected from carboxy-methyl cellulose, sodium carboxymethyl cellulose, carboxymethyl hydroxyethyl cellulose, carboxyethyl cellulose, hydroxyethylethyl cellulose, hydroxypropylmethyl cellulose, methyl cellulose, sodium methyl cellulose, microcrystalline cellulose, sodium cellulose sulfate, and mixtures thereof.
  • alkyl celluloses may also be selected from alkyl celluloses. These polymers are obtained by grafting an alkyl residue onto one or more hydroxy groups of the cellulose polymer to form the hydroxyalkyl derivative. These alkyl residues may be selected from the following groups: stearyl, isostearyl, lauryl, myristyl, cetyl, isocetyl, cocoyl, palmityl, oleyl, linonyl, ricinolyl, behenyl, and mixtures thereof. These hydroxyalkyl cellulose derivatives may also be subjected to chemical modification, e.g. using a carboxylic residue.
  • the superabsorbent material may also be selected from natural polymer derivatives, such as, for example, gellan gum and glucomannan and galactomannan polysaccharides extracted from seeds, vegetable fibers, fruit, seaweed, starch, plant resins, or indeed of microbial origin.
  • natural polymer derivatives such as, for example, gellan gum and glucomannan and galactomannan polysaccharides extracted from seeds, vegetable fibers, fruit, seaweed, starch, plant resins, or indeed of microbial origin.
  • it may be selected from agar gum, guar gum, gum tragacanth, carrageenan gum, konjac gum, locust bean gum, gellan gum, xanthan gum, and mixtures thereof.
  • the first composition of the present invention may comprise the at least one superabsorbent material in a content ranging from 0%to 80%by weight, especially from 50%to 80%by weight, or even the rest, relative to the total weight of the first composition.
  • the first composition further comprises additional fibers other than one formed from the at least one water insoluble salt of polyvalent metal, where the at least one water insoluble salt of polyvalent metal and the at least one water soluble polyhydroxy polymer are loaded to the additional fibers.
  • the water insoluble salt of polyvalent metal may be present in form of fiber. Then, the fiber of the at least one water insoluble salt of polyvalent metal may, solely or together with one or more other fibers, be formed into a water insoluble substrate. The water soluble polyhydroxy polymer is loaded to the substrate.
  • the water insoluble salt of polyvalent metal, as well as the water soluble polyhydroxy polymer may be each distributed uniformly in a water insoluble substrate.
  • water insoluble means that the substrate is not dissolvable in water, nor does it break apart upon immersion in water.
  • Embodiment 1 is a diagrammatic representation of Embodiment 1:
  • the substrate may be a woven or nonwoven fabric made of a fiber of the at least one water insoluble salt of polyvalent metal (also referred to as water insoluble polyvalent metal salt fiber hereinafter) together with at least one other fiber chosen from natural fibers such as cotton, pulp, bamboo and cellulose fibers, semi-natural fibers such as viscose rayon fibers, synthetic fibers such as polyester fibers, polyethylene terephthalate fibers, polyethylene fibers and polypropylene fibers. Two or more selected from the other fibers may be used in combination.
  • polyvalent metal also referred to as water insoluble polyvalent metal salt fiber hereinafter
  • fibers rich in hydroxy groups can be readily softened with a water soluble polyhydroxy polymer. Accordingly, fibers rich in hydroxy groups are preferably used according to the present invention. Such fibers can be regenerated cellulose or cotton fiber. Examples of fibers rich in hydroxy groups comprise Viscose, Modal, Lyocell, Cupro, Cotton and the like.
  • the substrate can be made into a wide variety of shapes and forms such as flat pads, thick pads, thin sheets of irregular thickness, depending on the desired use and characteristic of the kit.
  • the substrate is typically designed to fit the area of the skin in the case of mask to which topical application is desired.
  • the substrate is designed to correspond to the shape of the face avoiding the eye, nostril, and mouth areas, as necessary.
  • Non-limiting examples of the substrates useful in the present invention are described, for example, in the patent application WO 02/062132, or EP 2489286A.
  • the water insoluble polyvalent metal salt is preferably formed from an organic acid, especially higher saturated or unsaturated fatty acids, in particular those having 18 or more carbon atoms, e.g., stearic acid and oleic acid, or polycarboxylic acids, especially e.g., alginic acid, oxalic acid.
  • the water insoluble substrate or the fabric may comprise the water insoluble polyvalent metal salt fiber, especially calcium alginate fiber, in an amount ranging from 10%to 80%by weight, especially from 10%to 40%by weight, relative to the total weight of the water insoluble substrate or the fabric.
  • the water insoluble substrate or the fabric may comprise the at least one other fiber in an amount ranging from 10%to 80%by weight, especially from 50%to 80%by weight, relative to the total weight of the water insoluble substrate or the fabric.
  • a suitable nonwoven fabric comprising calcium alginate fiber is commercially available from the Sanjiang company under the name M762R-40CN.
  • Embodiment 2 is a diagrammatic representation of Embodiment 1:
  • the substrate may comprise a woven or nonwoven fabric consisting essentially of at least one fiber chosen from natural fibers such as cotton, pulp, bamboo and cellulose fibers, semi-natural fibers such as viscose rayon fibers, synthetic fibers such as polyester fibers, polyethylene terephthalate fibers, polyethylene fibers and polypropylene fibers.
  • the at least one water insoluble salt of polyvalent metal is distributed as uniformly as possible in the substrate.
  • the water insoluble salt of polyvalent metal is prepared into an aqueous dispersion, e.g., for water insoluble salt of calcium. Then, the dispersion is applied, e.g., through coating, spraying and the like, onto the substrate, so as to distribute uniformly the salt of calcium in the substrate in an amount sufficient to form a gel on the substrate with alginate.
  • the wet substrate loaded with the aqueous salt is subsequently dried.
  • the method to dry the tissue is not limited specifically. For industrial application, the wet substrate is dried in an economically effective manner.
  • water insoluble salt of polyvalent metal such as the salt of calcium, e.g., as water insoluble salt, in solid form is crushed into powder or particles, e.g., through milling, grinding and the like. Then, the powder or particle is applied uniformly onto the substrate.
  • the diameter of the powder or particle is not limited specifically, as long as the water insoluble salt of polyvalent metal can be distributed uniformly in the substrate in an amount sufficient to form a gel on the substrate with alginate.
  • the water insoluble polyvalent metal salt is preferably formed from an inorganic acid, e.g., one selected from the group consisting of sulfonic acid, carbonic acid, phosphoric acid meta-aluminic acid, silicic acid, preferably sulfonic acid.
  • an inorganic acid e.g., one selected from the group consisting of sulfonic acid, carbonic acid, phosphoric acid meta-aluminic acid, silicic acid, preferably sulfonic acid.
  • the water insoluble substrate or the fabric may comprise the water insoluble polyvalent metal salt, especially calcium salt, in an amount ranging from 0.01%to 5%by weight, preferably from 0.02%to 1%by weight, or preferably from 0.04%to 0.5%by weight, relative to the total weight of the water insoluble substrate or the fabric.
  • the water soluble polyhydroxy polymer is preferably combined with the water insoluble substrate.
  • the process to combine the water soluble polyhydroxy polymer with the water insoluble substrate is not limited specifically, as long as the water soluble polyhydroxy polymer can be distributed uniformly in the substrate in an amount sufficient to soften the substrate to the desirable extent.
  • the water soluble polyhydroxy polymer is prepared into an aqueous solution. Then, the water soluble polyhydroxy polymer is loaded onto the substrate, e.g., a mask tissue.
  • the water soluble polyhydroxy polymer is prepared into a suspension or paste, e.g., a water soluble water soluble polyhydroxy polymer suspended in or mixed with a medium other than water to form a suspension or paste thereof. Then, the suspension or paste is applied, e.g., through coating, spraying and the like, onto the substrate, so as to distribute uniformly the water soluble polyhydroxy polymer in the substrate in an amount sufficient to form a gel on the substrate with alginate.
  • a suspension or paste e.g., a water soluble water soluble polyhydroxy polymer suspended in or mixed with a medium other than water to form a suspension or paste thereof.
  • the suspension or paste is applied, e.g., through coating, spraying and the like, onto the substrate, so as to distribute uniformly the water soluble polyhydroxy polymer in the substrate in an amount sufficient to form a gel on the substrate with alginate.
  • the wet substrate loaded with the aqueous salt is subsequently dried.
  • the method to dry the tissue is not limited specifically.
  • the wet substrate is dried in an economically effective manner.
  • the water soluble polyhydroxy polymer in solid form is crushed into powder or particles, e.g., through milling, grinding and the like. Then, the powder or particle is applied uniformly onto the substrate.
  • the diameter of the powder or particle is not limited specifically, as long as the water soluble polyhydroxy polymer can be distributed uniformly in the substrate in an amount sufficient to soften the substrate.
  • the water insoluble substrate or the fabric may comprise the water soluble polyhydroxy polymer, e.g., HEC or HPC, in an amount ranging from 0.001%to 1%by weight, especially from 0.01%to 0.1%by weight, such as 0.01%to 0.06%, relative to the total weight of the, relative to the total weight of the water insoluble substrate or the fabric.
  • HEC water soluble polyhydroxy polymer
  • HPC water soluble polyhydroxy polymer
  • the kit according to the present invention comprises, separate from and isolated with the first composition (e.g. the water insoluble substrate) , a second composition.
  • the second composition as needed, impregnates, coats or is otherwise in contact with the first composition, so as to transform the texture of the first composition, for example, from tissue to gel.
  • the weight ratio of the first composition (e.g. the water insoluble substrate or the fabric) to the second composition ranges from 1: 3 to 1: 20, preferably from 1: 8 to 1: 15.
  • the second composition of the present invention at least comprises a) optionally, at least one water soluble chelating agent of the polyvalent metal ion and b) at least one water soluble gelatinizing agent, which is gelatinizable with the polyvalent metal ion.
  • the water insoluble polyvalent metal ion donator reacts with salt in solution and releases the polyvalent metal ions.
  • the second composition does not comprise component a) , i.e., the at least one water soluble chelating agent of the polyvalent metal ion
  • the polyvalent metal ions released into solution react with component b) , i.e., the at least one water soluble gelatinizing agent, directly.
  • component a) i.e., the at least one water soluble chelating agent of the polyvalent metal ion
  • the polyvalent metal ions released into solution react with component b) , i.e., the at least one water soluble gelatinizing agent, directly.
  • component a) most of the polyvalent metal ions released into solution would be trapped by the water soluble chelating agent. A few of free polyvalent metal ions in the solution react with the water soluble gelatinizing agent and start to gelatinize on the tissue surface.
  • the chelated polyvalent metal ions would be gradually released and then gelatinize on the tissue surface. After a short period of time, transformation of tissue texture and a homogeneous gel on the tissue surface would be observed.
  • the second composition according to the present invention comprises optionally component a) , i.e., at least one water soluble chelating agent of the polyvalent metal ion, to facilitate the texture transformation, and specially, to boost at least the moisture or actives delivery capacity.
  • the water soluble chelating agent of the polyvalent metal ion is water-soluble.
  • the water insoluble polyvalent metal ion donator releases few or more of the polyvalent metal ions into solution.
  • Both the chelating agent of the polyvalent metal ion and the water soluble gelatinizing agent are capable of being combined with the polyvalent metal ions.
  • the specific chelating agent according to the present invention conquers the gelatinizing agent in the competition of combination with the polyvalent metal ion, such that most of polyvalent metal ions released are trapped by the water soluble chelating agent. There are still a few of free polyvalent metal ions in the solution to react with the water soluble gelatinizing agent and start to gelatinize on the tissue surface. As the concentration of free polyvalent metal ions decreases over time, the chelated polyvalent metal ions would be gradually released and then gelatinize on the tissue surface. That is, the specific chelating agent according to the present invention serves as a reservoir of the polyvalent metal ions for the gelatinization on the tissue surface.
  • the useful chelating agent of the polyvalent metal ion comprises aminocarboxylic acids, e.g., elhylenediamine tetraacetic acid (EDTA) , aminotriacetic acid, diethylene triaminepentaacetic acid, and in particular the alkali metal salt thereof, e.g., N, N-bis (carboxymethyl) glutamic acid, tetrasodium EDTA, tetrasodium salt of N, N-bis (carboxymethyl) glutamic acid (glutamic acid diacetic acid, GLDA) ; hydroxy carboxylic acids, e.g., citric acid, tartaric acid, glucuronic acid, succinic acid, ethylenediamine disuccinic acid (EDDS) , and in particular the alkali metal salt thereof; hydroxy aminocarboxylic acids, e.g., hydroxyethylethylenediamine triacetic acid (HEDTA) , dihydroxy
  • EDTA
  • the at least one water soluble chelating agent of the polyvalent metal ion is an alkali metal hydroxy polycarboxylate represented by an alkane containing from 1 to 4 carbon atoms, preferably containing 2 or 3 carbon atoms, substituted by 1, 2, or 3 hydroxy groups (-OH) , preferably by one (1) hydroxy group, and further substituted by 2, 3, 4 or 5 carboxylate groups (-COOM) , preferably by 2 or 3 carboxylate groups (-COOM) , wherein the multiple groups M independently represent H or alkali metal, with the proviso that at least one of the groups M represents alkali metal, such as Na, K or Li, preferably all groups M represent alkali metal, such as Na, K or Li, preferably Na.
  • alkali metal hydroxy polycarboxylate represented by an alkane containing from 1 to 4 carbon atoms, preferably containing 2 or 3 carbon atoms, substituted by 1, 2, or 3 hydroxy groups (-OH) , preferably by one (1) hydroxy
  • the at least one alkali metal hydroxy polycarboxylate may be chosen from sodium tartrates, sodium citrates, potassium tartrates, potassium citrates, and hydrates thereof, preferably sodium citrates, in particularly trisodium citrate.
  • sodium citrates are used to indicate monosodium citrate, disodium citrate and trisodium citrate, and other alkali metal hydroxy polycarboxylates may be understood in a similar way.
  • the alkali metal mentioned above is preferably sodium or potassium, in particular sodium.
  • preferable chelating agents can comprise sodium citrate, tetrasodium EDTA, tetrasodium GLDA, trisodium EDDS, sodium phytate, or a mixture thereof.
  • the second composition of the present invention may comprise the at least one water soluble chelating agent of the polyvalent metal ion in a content ranging from 0.1%to 1%by weight, especially from 0.2%to 0.4%by weight, relative to the total weight of the second composition.
  • the second composition according to the present invention comprises at least one water soluble gelatinizing agent, which is gelatinizable with the polyvalent metal ion, to trigger the texture transformation.
  • water soluble gelatinizing agent specifically means one gelatinizable with the polyvalent metal ion from the first composition.
  • the water insoluble polyvalent metal ion donator releases few or more of the polyvalent metal ions into solution.
  • the gelatinizing agent can thus be anyone gelatinizable with the polyvalent metal ion.
  • the gelatinizing agent can comprise glutins, pectins, gellan gum, carrageenans, agars, alginic compounds and in particular alkali metal salts of alginic acid, e.g., sodium alginate, and mixtures thereof.
  • the gelatinizing agent and the chelating agent are both specifically selected where the gelatinizing agent has an ability of combining with the polyvalent metal ions lower than that of the chelating agent, such that the gelatinizing agent does not combine the free polyvalent metal ions released directly from the first composition, but combines with the polyvalent metal ions subsequently from the reservoir, i.e., the chelated polyvalent metal ions. Accordingly, a gel on the surface of the first composition can be formed.
  • Pectins are linear polymers of ⁇ -D-galacturonic acid (at least 65%) linked in positions 1 and 4 with a certain proportion of carboxylic groups esterified with a methanol group. About 20%of the sugars constituting the pectin molecule are neutral sugars (L-rhamnose, D-glucose, D-galactose, L-arabinose, D-xylose) . L-Rhamnose residues are found in all pectins, incorporated into the main chain in positions 1, 2.
  • Uronic acid molecules bear carboxyl functions. This function gives pectins the capacity for exchanging ions, when they are in COO - form. Divalent ions (in particular calcium) have the capacity of forming ionic bridges between two carboxyl groups of two different pectin molecules.
  • a certain proportion of the carboxylic groups are esterified with a methanol group.
  • the natural degree of esterification of a pectin may range between 70%(apple, lemon) and 10% (strawberry) depending on the source used.
  • pectins with a high degree of esterification it is possible to hydrolyse the-COOCH 3 groups, so as to obtain weakly esterified pectins.
  • the chain is thus more or less acidic.
  • HM (high-methoxy) pectins are thus defined as having a degree of esterification of greater than 50%
  • LM (low-methoxy) pectins are defined as having a degree of esterification of less than 50%.
  • the-OCH 3 group is substituted with a -NH 2 group.
  • Pectins are especially sold by the company Cargill under the name Unipectine TM , by the company CP-Kelco under the name Genu, and by Danisco under the name Grinsted Pectin.
  • Carrageenans are anionic polysaccharides constituting the cell walls of various red algae (Rhodophyceae) belonging to the Gigartinacae, Hypneaceae, Furcellariaceae and Polyideaceae families. They are generally obtained by hot aqueous extraction from natural strains of said algae. These linear polymers, formed by disaccharide units, are composed of two D-galactopyranose units linked alternately by ⁇ (1, 3) and ⁇ (1, 4) bonds. They are highly sulfated polysaccharides (20-50%) and the ⁇ -D-galactopyranosyl residues may be in 3, 6-anhydro form.
  • carrageenans which bear one sulfate-ester group
  • iota-carrageenans which bear two sulfate-ester groups
  • lambda-carrageenans which bear three sulfate-ester groups.
  • Carrageenans are composed essentially of potassium, sodium, magnesium, triethanolamine and/or calcium salts of polysaccharide sulfate esters.
  • Carrageenans are sold especially by the company SEPPIC under the name by the company Gelymar under the names and by the company Cargill, under the names Satiagel TM and Satiagum TM , and by the company CP-Kelco under the names and
  • Agars are galactose polysaccharides contained in the cell wall of some of these species of red algae (rhodophyceae) . They are formed from a polymer group whose base backbone is a ⁇ (1, 3) D-galactopyranose and ⁇ (1, 4) L 3-6 anhydrogalactose chain, these units repeating regularly and alternately. The differences within the agar family are due to the presence or absence of solvated methyl or carboxyethyl groups. These hybrid structures are generally present in variable percentage, depending on the species of algae and the harvest season.
  • Agar-agar is a mixture of polysaccharides (agarose and agaropectin) of high molecular mass, between 40000 and 300000 g. mol -1 . It is obtained by manufacturing algal extraction liquors, generally by autoclaving, and by treating these liquors which comprise about 2%of agar-agar, so as to extract the latter.
  • Agar is produced, for example, by the group B&V Agar Producers under the names Gold Agar, Agarite and Grand Agar by the company Hispanagar, and under the names Agar-Agar, QSA (Quick Soluble Agar) , and Puragar by the company Setexam.
  • Gellan gum is an anionic linear heteropolyoside based on oligoside units composed of 4 saccharides (tetra-oside) .
  • D-Glucose, L-rhamnose and D-glucuronic acid in 2: 1: 1 proportions are present in gellan gum in the form of monomer elements.
  • Kelcogel CG LA It is sold, for example, under the name Kelcogel CG LA by the company CP Kelco.
  • the gelatinizing agent is preferably chosen from alkali metal alginic compounds.
  • the particularly preferable gelatinizing agent is alginate, e.g., sodium or potassium alginate, especially sodium alginate.
  • the at least one water soluble gelatinizing agent is present in the second composition from 0.1%to 0.5%by weight, preferably from 0.1%to 0.3%by weight, relative to the total weight of the second composition.
  • the amounts of the chelating agent and the gelatinizing agent are so selected that the molar ratio of the moiety to be released from the chelating agent chelatable with the polyvalent cation to the moiety to be released from the gelatinizing agent gelatinizable with the polyvalent cation ranging from about 10: 1 to about 1: 1, preferably from about 5: 1 to about 2: 1.
  • alkali metal alginic compound in particular means alkali metal alginic acid salts (alginates) or alkali metal salts of alginic acid derivatives.
  • the alkali metal alginic compound is water-soluble.
  • Alginic acid a natural substance obtained from brown algae or from certain bacteria, is a polyuronic acid composed of two uronic acids linked together via 1, 4-glycoside bonds: ⁇ -D-mannuronic acid (M) and ⁇ -L-glucuronic acid (G) .
  • Alginic acid is capable of forming water-soluble salts (alginates) with alkali metals such as sodium, potassium or lithium. These alginates are water-soluble in aqueous medium at pH 4 but dissociate into alginic acid at a pH below 4.
  • Alginic acid or alginates may be chemically modified, especially with urea or urethane groups or by hydrolysis, oxidation, esterification, etherification, sulfatation, phosphatation, amination, amidation or alkylation reaction, or by several of these modifications, forming alginic acid derivatives, including salts.
  • These derivatives may be anionic, cationic, amphoteric or nonionic, and are capable of forming water-soluble salts with an alkali metal such as sodium, potassium or lithium, forming alkali metal salts of alginic acid derivatives.
  • alginates may be reacted with an alkylene oxide, such as ethylene oxide or propylene oxide, to form polyglycol alginates.
  • the polyglycol segment is bonded to alginates through the carboxyl group (s) .
  • alginates react with propylene oxide to form polypropylene glycol alginates (PPG alginates)
  • PPG alginates polypropylene glycol alginates
  • PEG alginates polyethylene glycol alginates
  • Preparation of polyglycol alginates is disclosed in Strong, U.S. Pat. No. 3,948,881, Pettitt, U.S. Pat. No. 3,772,266, and Steiner, U.S. Pat. No. 2,426,125.
  • the polyglycol alginate has a degree of esterification of about 40%to about 95%, more preferably about 70%to 95%.
  • Suitable alginates have a weight-average molecular weight of about 20,000 Daltons to about 500,000 Daltons.
  • the weight-average molecular weight is calculated by first determining the intrinsic viscosity, then using the Mark-Houwink Sakurada Equation, as in Martinsen, et al, "Comparison of Different Methods for Determination of Molecular Weights and Molecular Weight Distribution of Alginates" (Carbohydr. Polym., 15, 171-193, 1991) .
  • weight-average molecular weights indicated above are also valid for the alkali metal salts of alginic acid derivatives.
  • the alkali metal alginic compound may be chosen from sodium alginate and potassium alginate, preferably sodium alginate.
  • alkali metal alginic compounds that are suitable for use in the present invention may be represented, for example, by the products sold under the names Kelcosol, Satialgine TM , Cecalgum TM or Algogel TM by the company Cargill Products, under the name Protanal TM by the company FMC Biopolymer, under the name Alginate by the company Danisco, under the name Kimica Algin by the company Kimica, and under the names and by the company ISP.
  • the second composition according to the present invention comprises at least one aqueous phase.
  • the at least one aqueous phase comprises water.
  • the aqueous phase may also comprise water-miscible organic solvents (at room temperature: 25°C) , for instance monoalcohols containing from 2 to 6 carbon atoms, such as ethanol or isopropanol; polyols especially containing from 2 to 20 carbon atoms, preferably containing from 2 to 10 carbon atoms and preferentially containing from 2 to 6 carbon atoms, such as glycerol, propylene glycol, butylene glycol, pentylene glycol, hexylene glycol, dipropylene glycol or diethylene glycol; glycol ethers (especially containing from 3 to 16 carbon atoms) such as mono-, di- or tri-propylene glycol (C 1 -C 4 ) alkyl ethers, mono-, di- or tri-ethylene glycol (C 1 -C 4 ) alkyl ethers, and mixtures thereof.
  • monoalcohols containing from 2 to 6 carbon atoms, such as ethanol or is
  • the aqueous phase may also comprise any water-soluble or water-dispersible compound that is compatible with an aqueous phase, such as hydrophilic gelling agents, preservatives or surfactants, and mixtures thereof.
  • the second composition of the present invention may comprise the at least one aqueous phase in a content ranging from 10%to 99%by weight, especially from 50%to 99%by weight, and more particularly from 70%to 99%by weight, relative to the total weight of the second composition.
  • the second composition according to the present invention may comprise optionally at least one additional hydrophilic gelling agent.
  • hydrophilic gelling agent means a compound that is capable of gelling the aqueous phase, without combining with the polyvalent metal ions from the first composition.
  • the gelling agent may be water-soluble or water-dispersible.
  • hydrophilic gelling agent may be chosen from synthetic polymeric gelling agents, polymeric gelling agents that are natural or of natural origin, or a mixture thereof.
  • the term "synthetic" means that the polymer is neither naturally existing nor a derivative of a polymer of natural origin.
  • the synthetic polymeric gelling agent under consideration according to the present invention may or may not be particulate.
  • the term "particulate" when being used for the synthetic polymeric gelling agent, means that the polymer is in the form of particles, preferably spherical particles.
  • these polymers may be chosen especially from:
  • modified or unmodified carboxyvinyl polymers such as the products sold under the name (CTFA name: Carbomer) by the company Goodrich; polyacrylates, polymethacrylates such as the products sold under the names Lubrajel TM and Norgel by the company Guardian or under the name by the company Hispano Chimica; polyacrylamides; optionally crosslinked and/or neutralized 2-acrylamido-2-methylpropanesulfonic acid polymers and copolymers, for instance the poly (2-acrylamido-2-methylpropanesulfonic acid) sold by the company Clariant under the name Hostacerin (CTFA name: ammonium polyacryldimethyltauramide) ; crosslinked anionic copolymers of acrylamide and of which are in the form of a W/O emulsion, such as those sold under the name Sepigel TM 305 (CTFA name: Polyacrylamide/C 13-14 isoparaffin/Laureth-7) and under the name Simulgel TM 600 (CTFA name: Acryl
  • these polymers may be chosen from Acrylates/C 10-30 Alkyl Acrylate Crosspolymer such as, ultrez 20, ultrez 21, Permulen TM TR-1, Permulen TM TR-2, 1382, ETD 2020, Carbomer such as K, 980, Ammonium acryloyldimethyl Taurate/Steareth-8 Methacrylate copolymer such as SNC, Acrylates copolymer such as Aqua SF-1, Ammonium acryloyldimethyl taurate/steareth-25 Methacrylate Crosspolymer such as HMS, Ammonium acryloyldimethyl taurate such as AVC.
  • Acrylates/C 10-30 Alkyl Acrylate Crosspolymer such as, ultrez 20, ultrez 21, Permulen TM TR-1, Permulen TM TR-2, 1382, ETD 2020, Carbomer such as K, 980, Ammonium acryloyldimethyl Taurate/Steareth-8 Methacrylate cop
  • these polymers may be chosen from carboxyvinyl polymers such as the products (carbomers) such as Ultrez 20 Polymer marketed by Lubrizol and the Pemulen products (acrylate/C 10-30 alkylacrylate copolymer) ; polyacrylamides, for instance the crosslinked copolymers marketed under the trademarks Sepigel TM 305 (CTFA name: polyacrylamide/C 13-14 isoparaffin/Laureth-7) or Simulgel TM 600 (CTFA name: acrylamide/sodium acryloyldimethyltaurate copolymer/isohexadecane/polysorbate 80) by SEPPIC; 2-acrylamido-2-methylpropanesulfonic acid polymers and copolymers, which are optionally crosslinked and/or neutralized, for instance the poly (2-acrylamido-2-methylpropanesulfonic acid) marketed by Hoechst under the trademark Hostacerin (CTFA name: ammonium polyacryloyldi
  • these polymers may be chosen from glyceryl acrylate/acrylic acid copolymers available from ISP Technologies, Inc. (United Guardian Inc. ) under the tradename Lubrajel TM , particular the form known as Lubrajel TM oil which contains about 1.0%-1.3%glyceryl acrylate/acrylic acid copolymer in aqueous glycerin (about 40%glycerin) .
  • Lubrajel TM oil also includes about 0.6%PVM/MA copolymer (also known as methoxyethylene/maleic anhydride copolymer) .
  • the term "of natural origin” is intended to denote polymeric gelling agents obtained by modification of natural polymeric gelling agents.
  • These gelling agents may be particulate or non-particulate.
  • these gelling agents fall within the category of polysaccharides.
  • polysaccharides that are suitable for use in the present invention may be homopolysaccharides such as fructans, glucans, galactans and mannans or heteropolysaccharides such as hemicellulose.
  • they may be linear polysaccharides such as pullulan or branched polysaccharides such as gum arabic and amylopectin, or mixed polysaccharides such as starch.
  • the polysaccharides may be chosen from ones produced by microorganisms; polysaccharides isolated from algae, and higher plant polysaccharides, such as homogeneous polysaccharides, in particular celluloses and derivatives thereof or fructosans, heterogeneous polysaccharides such as gum arables, galactomannans, glucomannans, and derivatives thereof; and mixtures thereof.
  • the polysaccharides may be chosen from fructans, gellans, glucans, amylose, amylopectin, glycogen, pullulan, dextrans, celluloses and derivatives thereof, in particular methylcelluloses, hydroxyalkylcelluloses, ethylhydroxyethylcelluloses and carboxymethylcelluloses, mannans, xylans, lignins, arabans, galactans, galacturonans, chitin, chitosans, glucuronoxylans, arabinoxylans, xyloglucans, glucomannans, arabinogalactans, glycosaminoglucans, gum arables, tragacanth gums, ghatti gums, locust bean gums, galactomannans such as guar gums and nonionic derivatives thereof, in particular hydroxypropyl guar, and ionic derivatives thereof, biopoly saccharide gums of microbial origin, in particular
  • polysaccharides may be chemically modified, especially with urea or urethane groups or by hydrolysis, oxidation, esterification, etherification, sulfatation, phosphatation, amination, amidation or alkylation reaction, or by several of these modifications.
  • the derivatives obtained may be anionic, cationic, amphoteric or nonionic.
  • the polysaccharides may be chosen from xanthan gum, scleroglucan gum, guar gum, inulin and pullulan, and mixtures thereof.
  • the compounds of this type that may be used in the present invention are chosen from those described especially in Kirk-Othmer's Encyclopedia of Chemical Technology, Third Edition, 1982, volume 3, pp. 896-900, and volume 15, pp. 439-458, in Polymers in Nature by E.A. MacGregor and C.T. Greenwood, published by John Wiley&Sons, Chapter 6, pp. 240-328, 1980, in the book by Robert L. Davidson entitled Handbook of Water-Soluble Gums and Resins published by McGraw Hill Book Company (1980) and in Industrial Gums-Polysaccharides and their Derivatives, edited by Roy L. Whistler, Second Edition, published by Academic Press Inc.
  • these polysaccharides that are suitable for use in the present invention may be distinguished according to whether they are derived from microorganisms, from algae or from higher plants, and are detailed below.
  • Xanthan is a heteropolysaccharide produced at the industrial scale by the aerobic fermentation of the bacterium Xanthomonas campestris. Its structure consists of a main chain of ⁇ (1, 4) -linked ⁇ -D-glucoses, similar to cellulose. One glucose molecule in two bears a trisaccharide side chain composed of an ⁇ -D-mannose, a ⁇ -D-glucuronic acid and a terminal ⁇ -D-mannose. The internal mannose residue is generally acetylated on carbon 6. About 30%of the terminal mannose residues bear a pyruvate group linked in chelated form between carbons 4 and 6.
  • the charged pyruvic acids and glucuronic acids are ionizable, and are thus responsible for the anionic nature of xanthan (negative charge down to a pH equal to 1) .
  • the content of pyruvate and acetate residues varies according to the bacterial strain, the fermentation process, the conditions after fermentation and the purification steps. These groups may be neutralized in commercial products with Na + , K + or Ca 2+ ions (Satia company, 1986) .
  • the neutralized form may be converted into the acid form by ion exchange or by dialysis of an acidic solution.
  • Xanthan gums have a molecular weight of between 1 000 000 and 50 000 000 and a viscosity of between 0.6 and 1.65 Pa. s for an aqueous composition containing 1%of xanthan gum (measured at 25°C on a Brookfield viscometer of LVT type at 60 rpm) .
  • Xanthan gums are represented, for example, by the products sold under the names Rhodicare by the company Rhodia Chimie, under the name Satiaxane TM by the company Cargill Texturizing Solutions (for the food, cosmetic and pharmaceutical industries) , under the name Novaxan TM by the company ADM, and under the names and by the company CP-Kelco.
  • Pullulan is a polysaccharide consisting of maltotriose units, known under the name ⁇ (1, 4) - ⁇ (1, 6) -glucan. Three glucose units in maltotriose are connected via an ⁇ (1, 4) glycoside bond, whereas the consecutive maltotriose units are connected to each other via an ⁇ (1, 6) glycoside bond.
  • Pullulan is produced, for example, under the reference Pullulan PF 20 by the group Hayashibara in Japan.
  • Dextran is a neutral polysaccharide not bearing any charged groups, which is biologically inert, prepared by fermentation of beet sugar containing solely hydroxy groups. It is possible to obtain dextran fractions of different molecular weights from native dextran by hydrolysis and purification. Dextran may in particular be in the form of dextran sulfate.
  • Dextran is represented, for example, by the products sold under the name Dextran or Dextran T by the company Pharmacosmos, or under the name Dextran 40 Powder or Dextran 70 Powder by the company Meito Sangyo Co.
  • Dextran sulfate is sold by the company PK Chemical A/S under the name Dextran sulfate.
  • Succinoglycan is an extracellular polymer of high molecular weight produced by bacterial fermentation, consisting of octasaccharide repeating units (repetition of 8 sugars) .
  • Succinoglycans are sold, for example, under the name Rheozan by the company Rhodia. Scleroglucan
  • Scleroglucan is a nonionic branched homopolysaccharide consisting of ⁇ -D-glucan units.
  • the molecules consist of a linear main chain formed from D-glucose units linked via ⁇ (1, 3) bonds and of which one in three is linked to a side D-glucose unit via a ⁇ (1, 6) bond.
  • Scleroglucan is sold, for example, under the name Amigel by the company Alban Miiller, or under the name Actigum TM CS by the company Cargill.
  • Furcellaran is obtained commercially from red algae Furcellaria fasztigiata. Furcellaran is produced, for example, by the company Est-Agar.
  • This category of polysaccharides may be divided into homogeneous polysaccharides (only one saccharide species) and heterogeneous polysaccharides composed of several types of saccharides.
  • the polysaccharide according to the present invention may be chosen from celluloses and derivatives or fructosans.
  • the polysaccharide according to the present invention may also be a cellulose or a derivative thereof, especially cellulose ethers or esters (e.g. methylcellulose, carboxymethylcellulose, hydroxymethylcellulose, hydroxyethylcellulose, hydroxypropylcellulose, hydroxymethylpropylcellulose, cellulose acetate, cellulose nitrate, nitrocellulose) .
  • cellulose ethers or esters e.g. methylcellulose, carboxymethylcellulose, hydroxymethylcellulose, hydroxyethylcellulose, hydroxypropylcellulose, hydroxymethylpropylcellulose, cellulose acetate, cellulose nitrate, nitrocellulose
  • the present invention may also contain a cellulose-based associative polymer.
  • the repeating unit is the cellobiose dimer.
  • the AGUs are in chair conformation and bear 3 hydroxy functions: 2 secondary alcohols (in position 2 and 3) and a primary alcohol (in position 6) .
  • the polymers thus formed combine together via intermolecular bonds of hydrogen bond type, thus giving the cellulose a fibrillar structure (about 1500 molecules per fibre) .
  • the degree of polymerization differs enormously depending on the origin of the cellulose; its value may range from a few hundred to several tens of thousands.
  • the hydroxy groups of cellulose may react partially or totally with various chemical reagents to give cellulose derivatives having intrinsic properties.
  • the cellulose derivatives may be anionic, cationic, amphoteric or nonionic.
  • cellulose ethers, cellulose esters and cellulose ester ethers are distinguished.
  • nonionic cellulose ethers mention may be made of alkylcelluloses such as methylcelluloses and ethylcelluloses; hydroxyalkylcelluloses such as hydroxymethylcelluloses, hydroxyethylcelluloses and hydroxypropylcelluloses; and mixed hydroxyalkylalkylcelluloses such as hydroxypropylmethylcelluloses, hydroxy-ethylmethylcelluloses, hydroxy ethylethylcelluloses and hydroxybutylmethylcelluloses.
  • alkylcelluloses such as methylcelluloses and ethylcelluloses
  • hydroxyalkylcelluloses such as hydroxymethylcelluloses, hydroxyethylcelluloses and hydroxypropylcelluloses
  • mixed hydroxyalkylalkylcelluloses such as hydroxypropylmethylcelluloses, hydroxy-ethylmethylcelluloses, hydroxy ethylethylcelluloses and hydroxybutylmethylcelluloses.
  • the hydroxyalkylcellulose as a nonionic cellulose ether, belongs to the category of nonionic polysaccharide, such that it can be useful as the water soluble polyhydroxy polymerto soften fibers rich in hydroxy groups.
  • the first composition comprises fibers rich in hydroxy groups
  • the second composition comprises hydroxyalkylcelluloses.
  • anionic cellulose ethers mention may be made of carboxyalkylcelluloses and salts thereof.
  • cationic cellulose ethers mention may be made of crosslinked or non-crosslinked, quaternized hydroxyethylcelluloses.
  • the quaternizing agent may in particular be glycidyltrimethylammonium chloride or a fatty amine such as laurylamine or stearylamine.
  • a fatty amine such as laurylamine or stearylamine.
  • Another cationic cellulose ether that may be mentioned is hydroxy ethylcellulosehydroxypropyltrimethylammonium.
  • the quaternized cellulose derivatives are, in particular:
  • - quaternized celluloses modified with groups comprising at least one fatty chain, such as alkyl, arylalkyl or alkylaryl groups comprising at least 8 carbon atoms, or mixtures thereof,
  • - quaternized hydroxyethylcelluloses modified with groups comprising at least one fatty chain, such as alkyl, arylalkyl or alkylaryl groups comprising at least 8 carbon atoms, or mixtures thereof.
  • the alkyl radicals borne by the above quaternized celluloses or hydroxyethylcelluloses preferably contain from 8 to 30 carbon atoms.
  • the aryl radicals preferably denote phenyl, benzyl, naphthyl or anthryl groups.
  • Examples of quaternized alkylhydroxyethylcelluloses containing C 8-30 fatty chains that may be indicated include the products Quatrisoft LM 200, Quatrisoft LM-X 529-18-A, Quatrisoft LM-X 529-18B (C 12 alkyl) and Quatrisoft LM-X 529-8 (C 18 alkyl) sold by the company Amerchol and the products Crodacel QM, Crodacel QL (C 12 alkyl) and Crodacel QS (C 18 alkyl) sold by the company Croda.
  • - celluloses modified with groups comprising at least one fatty chain for instance hydroxyethylcelluloses modified with groups comprising at least one fatty chain, such as alkyl groups, especially of C 8-22 , arylalkyl and alkylaryl groups, such as Natrosol Plus Grade 330 CS (C 16 alkyls) sold by the company Aqualon, and
  • polyalkylene glycol alkylphenyl ether groups such as the product Amercell Polymer HM-1500 (nonylphenyl polyethylene glycol (15) ether) sold by the company Amerchol.
  • cellulose esters are mineral esters of cellulose (cellulose nitrates, sulfates, phosphates, etc. ) , organic cellulose esters (cellulose monoacetates, triacetates, amidopropionates, acetatebutyrates, acetatepropionates and acetatetrimellitates, etc. ) , and mixed organic/mineral esters of cellulose, such as cellulose acetatebutyrate sulfates and cellulose acetatepropionate sulfates.
  • cellulose ester ethers mention may be made of hydroxypropylmethylcellulose phthalates and ethylcellulose sulfates.
  • the cellulose-based compounds of the present invention may be chosen from unsubstituted celluloses and substituted celluloses.
  • the celluloses and derivatives are represented, for example, by the products sold under the names (microcrystalline cellulose, MCC) by the company FMC Biopolymers, under the name Cekol (carboxymethylcellulose) by the company Noviant (CP-Kelco) , under the name Akucell AF(sodium carboxymethylcellulose) by the company Akzo Nobel, under the name Methocel TM (cellulose ethers) and Ethocel TM (ethylcellulose) by the company Dow, and under the names (carboxymethylcellulose and sodium carboxymethylcellulose) , (methylcellulose) , Blanose TM (carboxymethylcellulose) , (methylcellulose, hydroxypropylmethylcellulose) , (hydroxypropylcellulose) , (cetylhydroxyethylcellulose) and CS (hydroxy ethylcellulose) by the company Hercules Aqualon.
  • the polysaccharide according to the present invention may especially be a fructosan chosen from inulin and derivatives thereof (especially dicarboxy and carboxymethyl inulins) .
  • Fructans or fructosans are oligosaccharides or polysaccharides comprising a sequence of anhydrofructose units optionally combined with several saccharide residues other than fructose.
  • Fructans may be linear or branched.
  • Fructans may be products obtained directly from a plant or microbial source or alternatively products whose chain length has been modified (increased or decreased) by fractionation, synthesis or hydrolysis, in particular enzymatic.
  • Fructans generally have a degree of polymerization from 2 to about 1000 and preferably from 2 to about 60.
  • the first group corresponds to products whose fructose units are for the most part linked via ⁇ (2, 1) bonds. These are essentially linear fructans such as inulins.
  • the second group also corresponds to linear fructoses, but the fructose units are essentially linked via ⁇ (2, 6) bonds. These products are levans.
  • the third group corresponds to mixed fructans, i.e. containing ⁇ (2, 6) and ⁇ (2, 1) sequences. These are essentially branched fructans, such as graminans.
  • the preferred fructans in the compositions according to the present invention are inulins.
  • Inulin may be obtained, for example, from chicory, dahlia or Jerusalem artichoke, preferably from chicory.
  • the polysaccharide especially the inulin, has a degree of polymerization from 2 to about 1000 and preferably from 2 to about 60, and a degree of substitution of less than 2 on the basis of one fructose unit.
  • the inulin used for the present invention is represented, for example, by the products sold under the name Beneo TM inulin by the company Orafti, and under the name by the company Sensus.
  • the polysaccharides that may be used according to the present invention may be gums, for instance cassia gum, karaya gum, konjac gum, gum tragacanth, tara gum, acacia gum or gum arabic.
  • Gum arabic is a highly branched acidic polysaccharide which is in the form of mixtures of potassium, magnesium and calcium salts.
  • the monomer elements of the free acid (arabic acid) are D-galactose, L-arabinose, L-rhamnose and D-glucuronic acid.
  • Galactomannans guar, locust bean, fenugreek, tara gum
  • derivatives guar phosphate, hydroxypropyl guar, etc.
  • Galactomannans are nonionic polyosides extracted from the endosperm of leguminous seeds, of which they constitute the storage carbohydrate.
  • Galactomannans are macromolecules consisting of a main chain of ⁇ (1, 4) -linked D-mannopyranose units, bearing side branches consisting of a single D-galactopyranose unit ⁇ (1, 6) -linked to the main chain.
  • the various galactomannans differ, firstly, by the proportion of ⁇ -D-galactopyranose units present in the polymer, and secondly, by significant differences in terms of distribution of galactose units along the mannose chain.
  • the mannose/galactose (M/G) ratio is about 2 for guar gum, 3 for tara gum and 4 for locust bean gum.
  • Guar gum is characterized by a mannose/galactose ratio of the order of 2/1.
  • the galactose group is regularly distributed along the mannose chain.
  • guar gums that may be used according to the present invention may be nonionic, cationic or anionic. According to the present invention, use may be made of chemically modified or unmodified nonionic guar gums.
  • the unmodified nonionic guar gums are, for example, the products sold under the names Vidogum GH, Vidogum G and Vidocrem by the company Unipektin and under the name Jaguar by the company Rhodia, under the name Guar by the company Danisco, under the name Viscogum TM by the company Cargill, and under the name guar gum by the company Aqualon.
  • hydrolysed nonionic guar gums that may be used according to the present invention are represented, for example, by the products sold under the name by the company Danisco.
  • modified nonionic guar gums that may be used according to the present invention are preferably modified with C 1-6 hydroxyalkyl groups, among which mention may be made, for example, of hydroxymethyl, hydroxyethyl, hydroxypropyl and hydroxybutyl groups.
  • nonionic guar gums optionally modified with hydroxyalkyl groups are sold, for example, under the trade names Jaguar HP 60, Jaguar HP 105 and Jaguar HP 120 (hydroxypropyl guar) by the company Rhodia or under the name HP (hydroxypropyl guar) by the company Aqualon.
  • the cationic galactomannan gums preferably have a cationic charge density of less than or equal to 1.5 meq. /g, more particularly between 0.1 and 1 meq. /g.
  • the charge density may be determined by the Kjeldahl method. It generally corresponds to a pH of the order of 3 to 9.
  • cationic galactomannan gum means any galactomannan gum containing cationic groups and/or groups that can be ionized into cationic groups.
  • the preferred cationic groups are chosen from those comprising primary, secondary, tertiary and/or quaternary amine groups.
  • the cationic galactomannan gums used generally have a weight-average molecular mass of between 500 and 5 ⁇ 10 6 approximately and preferably between 10 3 and 3 ⁇ 10 6 approximately.
  • the cationic galactomannan gums that may be used according to the present invention are, for example, gums comprising tri (C 1-4 ) alkylammonium cationic groups. Preferably, 2%to 30%by number of the hydroxy functions of these gums bear trialkylammonium cationic groups.
  • trialkylammonium groups mention may be made most particularly of trimethylammonium and triethylammonium groups.
  • these groups represent from 5%to 20%by weight relative to the total weight of the modified galactomannan gum.
  • the cationic galactomannan gum is preferably a guar gum comprising hydroxypropyltrimethylammonium groups, i.e. a guar gum modified, for example, with 2, 3-epoxypropyltrimethylammonium chloride.
  • galactomannan gums in particular guar gums modified with cationic groups are products already known per se and are, for example, described in patents US 3 589 578 and US 4 031 307.
  • Such products are moreover sold especially under the trade names Jaguar EXCEL, Jaguar C13 S, Jaguar C 15, Jaguar C 17 and Jaguar CI 62 (Guar Hydroxypropyltrimonium Chloride) by the company Rhodia, under the name Guar (Guar Hydroxypropyltrimonium Chloride) by the company Degussa, and under the name 3000 (Guar Hydroxypropyltrimonium Chloride) by the company Aqualon.
  • the anionic guar gums that may be used according to the present invention are polymers comprising groups derived from carboxylic, sulfonic, sulfenic, phosphoric, phosphonic or pyruvic acid.
  • the anionic group is preferably a carboxylic acid group.
  • the anionic group may also be in the form of an acid salt, especially a sodium, calcium, lithium or potassium salt.
  • anionic guar gums that may be used according to the present invention are preferentially carboxymethyl guar derivatives (carboxymethyl guar or carboxymethyl hydroxypropyl guar) .
  • Locust bean gum is extracted from the seeds of the locust bean tree Ceratonia siliqua) .
  • the unmodified locust bean gum that may be used in the present invention is sold, for example, under the name Viscogum TM by the company Cargill, under the name Vidogum L by the company Unipektin and under the name LBG by the company Danisco.
  • the chemically modified locust bean gums that may be used in the present invention may be represented, for example, by the cationic locust beans sold under the name Catinal CLB (locust bean hydroxypropyltrimonium chloride) by the company Toho.
  • Catinal CLB locust bean hydroxypropyltrimonium chloride
  • the tara gum that may be used in the context of the present invention is sold, for example, under the name Vidogum SP by the company Unipektin.
  • Glucomannan is a polysaccharide of high molecular weight (500 000 ⁇ Mglucomannan ⁇ 2 000 000) composed of D-mannose and D-glucose units with a branch every 50 or 60 units approximately. It is found in wood, but is also the main constituent of konjac gum. Konjac (Amorphophallus konjac) is a plant of the Araceae family.
  • chitin poly-N-acetyl-D-glucosamine, ⁇ (1, 4) -2-acetamido-2-deoxy-D-glucose
  • chitosan and derivatives chitosan- ⁇ -glycerophosphate, carboxymethylchitin, etc.
  • glycosaminoglycans such as hyaluronic acid, chondroitin sulfate, dermatan sulfate, keratan sulfate, and preferably hyaluronic acid
  • xylans or arabinoxylans
  • Arabinoxylans are polymers of xylose and arabinose, all grouped under the name pentosans.
  • Xylans consist of a main chain of ⁇ (1, 4) -linked D-xylose units and on which are found three substituents (Rouau&Thibault, 1987) : acid units, ⁇ -L-arabinofuranose units, side chains which may contain arabinose, xylose, galactose and glucuronic acid.
  • the polysaccharide is preferably hyaluronic acid, or a salt thereof.
  • the at least one hydrophilic gelling agent may be present in an amount ranging for example from 0.001 to 10%by weight, preferably 0.01 to 5%by weight and more preferably from 0.05 to 3%by weight relative to the total weight of the second composition.
  • the first composition may comprise at least one active agent.
  • the second composition may comprise at least one active agent.
  • the first composition includes the at least one active agent
  • it may be incorporated into the first composition in particular by means of an alternating electric field.
  • the active agent (s) may be incorporated in particular in the powder state.
  • ⁇ - or ⁇ -hydroxy acids such as lactic acid, glycolic acid, citric acid, 5-octanoylsalicyclic acid, ⁇ -hydroxydecanoic acid, ⁇ -hydroxylauric, tartaric acid, glucuronic acid, galacturonic acid, acrylic acid, ⁇ -hydroxybutyric acid, ⁇ -hydroxyisobutyric acid, malic acid, mandelic acid, phosphoric acid, pyruvic acid, lactobionic acid, and salicylic acid.
  • ⁇ - or ⁇ -hydroxy acids such as lactic acid, glycolic acid, citric acid, 5-octanoylsalicyclic acid, ⁇ -hydroxydecanoic acid, ⁇ -hydroxylauric, tartaric acid, glucuronic acid, galacturonic acid, acrylic acid, ⁇ -hydroxybutyric acid, ⁇ -hydroxyisobutyric acid, malic acid, mandelic acid, phosphoric acid, pyruvic acid, lactobionic acid, and salicylic
  • anti-acne agents such as salicylic acid or benzoyl peroxide, octopirox, dextrorotary and levorotary sulfur-containing amino acids, their salts, and their N-acetyl derivatives such as N-acetyl cysteine, or agents seeking to prevent aging of the skin and/or to improve its state, for example the above-mentioned ⁇ -and ⁇ -hydroxy acids, retinoids such as retinoic acid, retinol, and its esters, such as, for example, retinyl propionate, and retinyl acetate, or retinyl palmitate, niacinamide, allantoin, extracts of aloe, azelaic acid, bisabolol, phytic acid, collagen, or agents stimulating the formation of collagen, vitamins such as vitamin C or derivatives thereof, such as ascorbyl glucoside, vitamin E or derivatives thereof, vitamin A or derivatives thereof, vitamin
  • active agents for improving the condition of the skin in the case of mask, such as moisturizers or agents serving to improve the natural lipid barrier, such as ceramides, cholesterol sulfates, and/or fatty acids, and mixtures thereof.
  • active agents for improving the condition of the skin such as moisturizers or agents serving to improve the natural lipid barrier, such as ceramides, cholesterol sulfates, and/or fatty acids, and mixtures thereof.
  • enzymes that have activity on the skin such as proteases, lipases, cerebrosidases, and/or melanases, and mixtures thereof.
  • active agents there are agents for drugs, peptides, proteins, detectable labels, contrast reagents, pain-killing, anesthetics, antibacterial agents, anti-yeast agents, antifungal agents, antiviral agents, anti-dermititis agents, anti-pruritic agents, anti-emetics, vascular protectors, agents against motion sickness, anti-irritants, anti-inflammatory agents, immunomodulators, anti-hyperkeratolytic agents, agents for treating dry skin, antiperspirants, anti-psoriatic agents, antidandruff agents, anti-aging agents, anti-asthmatic agents and bronchodilators, sunscreen agents, antihiistamnes, healing agents, corticosteroids, tanning agents, and mixtures thereof.
  • the content of the at least one active agent in the first composition and/or in the second composition may be adjusted as a function of the intended purpose of the kit.
  • Hyaluronic compound may be also used as an active agent according to the present invention.
  • the hyaluronic compound is preferably an alkali metal hyaluronic compound.
  • alkali metal hyaluronic compound in particular means alkali metal salts of hyaluronic acid (hyaluronates) or derivatives thereof.
  • the alkali metal hyaluronic compound is water-soluble.
  • hyaluronic acid or derivatives thereof covers in particular the basic unit of hyaluronic acid of formula:
  • hyaluronic acid comprising a disaccharide dimer, namely D-glucuronic acid and N-acetylglucosamine.
  • hyaluronic acid or derivatives thereof also comprises, in the context of the present invention, the linear polymer comprising the polymeric unit described above, linked together in the chain via alternating ⁇ (1, 4) and ⁇ (1, 3) glycosidic linkages, having a molecular weight (Mw) that can range between 380 and 13 000 000 daltons. This molecular weight depends in large part on the source from which the hyaluronic acid is obtained and/or on the preparation methods.
  • Mw molecular weight
  • hyaluronic acid is present in pericellular gels, in the base substance of the connective tissues of vertebrate organs such as the dermis and epithelial tissues, and in particular in the epidermis, in the synovial fluid of the joints, in the vitreous humor, in the human umbilical cord and in the crista galli apophysis.
  • hyaluronic acid or derivatives thereof comprises all the fractions or subunits of hyaluronic acid having a molecular weight in particular within the molecular weight range recalled above.
  • the hyaluronic acid fractions suitable for the use covered by the present invention have a molecular weight of between 50 000 and 5 000 000, in particular between 100 000 and 5 000 000, especially between 400 000 and 5 000 000 Da.
  • the term used is high-molecular-weight hyaluronic acid.
  • the hyaluronic acid fractions that may also be suitable for the use covered by the present invention have a molecular weight of between 50 000 and 400 000 Da.
  • the term used is intermediate-molecular-weight hyaluronic acid.
  • the hyaluronic acid fractions that may be suitable for the use covered by the present invention have a molecular weight of less than 50 000 Da.
  • the term used is low-molecular-weight hyaluronic acid.
  • hyaluronic acid or derivatives thereof also comprises hyaluronic acid esters in particular those in which all or some of the carboxylic groups of the acid functions are esterified with oxyethylenated alkyls or alcohols, containing from 1 to 20 carbon atoms, in particular with a degree of substitution at the level of the D-glucuronic acid of the hyaluronic acid ranging from 0.5 to 50%.
  • hyaluronic acid or hyaluronates may be reacted with an alkylene oxide, such as ethylene oxide or propylene oxide, to form polyglycol hyaluronates.
  • alkylene oxide such as ethylene oxide or propylene oxide
  • the polyglycol segment is bonded to hyaluronic acid through the carboxyl group (s) .
  • hyaluronic acid or hyaluronates react with propylene oxide to form polypropylene glycol hyaluronates, while react with ethylene oxide to form polyethylene glycol hyaluronates.
  • esters of hyaluronic acid include methyl, ethyl, n-propyl, n-pentyl, benzyl and dodecyl esters of hyaluronic acid. Such esters have in particular been described in D. Campoccia et al. "Semisynthetic resorbable materials from hyaluronan esterification” , Biomaterials 19 (1998) 2101-2127.
  • the second composition of the present invention may also contain adjuvants that are common in cosmetics and/or dermatology, such as preserving agents, antioxidants, pH modifiers (acidic or basic) , fragrances, fillers, bactericides, odour absorbers, colorants (pigments and dyes) , emulsifiers, and also lipid vesicles.
  • adjuvants that are common in cosmetics and/or dermatology, such as preserving agents, antioxidants, pH modifiers (acidic or basic) , fragrances, fillers, bactericides, odour absorbers, colorants (pigments and dyes) , emulsifiers, and also lipid vesicles.
  • the second composition according to the present invention may be in various forms, in particular in the form of aqueous solution, dispersion, or emulsion, especially such as a water/oil or oil/water emulsion or multiple emulsions.
  • An emulsion may have an oily or aqueous continuous phase.
  • Such an emulsion may be, for example, an inverse (W/O) emulsion or a direct (O/W) emulsion, or alternatively a multiple emulsion (W/O/W or O/W/O) .
  • the second composition according to the present invention may be in the form of an oil-in-water (O/W) emulsion, water-in-oil (W/O) emulsion, or a multiple emulsion, preferably a oil-in-water (O/W) emulsion.
  • O/W oil-in-water
  • W/O water-in-oil
  • W/W multiple emulsion
  • the second composition of the present invention is preferably an aqueous solution.
  • the kit presents as a mask comprising:
  • a nonwoven fabric made of fibers rich in hydroxy groups, comprising from 0.01%to 5%by weight, preferably from 0.02%to 1%by weight, or preferably from 0.04%to 0.5%, of calcium sulphate or calcium carbonate, and from 0.001%to 1%by weight, especially from 0.01%to 0.1%by weight, such as 0.01%to 0.06%, of HEC or HPC, relative to the total weight of the nonwoven fabric, and
  • composition comprising from 10%to 99%by weight, preferably from 50%to 99%by weight, of the at least one aqueous phase, from 0.1%to 0.5%by weight, preferably from 0.1%to 0.3%by weight, of sodium alginate, and from 0.1%to 0.5%by weight, preferably from 0.2%to 0.4%by weight, of sodium citrate, relative to the total weight of the composition,
  • weight ratio of the nonwoven fabric to the composition ranges from 1: 3 to 1: 20, preferably from 1: 8 to 1: 15.
  • a mask package 1 comprising:
  • a first composition comprising at least one water insoluble salt of polyvalent metal and at least one water soluble polyhydroxy polymer
  • first composition and the fourth composition are separately placed from one another.
  • the first composition as well as the components thereof, including the water insoluble salt and the water soluble polyhydroxy polymer, and the fourth composition, including the water soluble chelating agent, the water soluble gelatinizing agent and others can be substantially same as the kit of the invention, where the fourth composition corresponds substantially to the second composition, except for the absence of water.
  • the structure of the mask package 1 can be substantially same as the kit of the invention.
  • the amounts of the compositions, the components of the compositions and the ratios therebetween of the mask package 1 can refer to the kit of the present invention.
  • the fourth composition can be mixed with water to form an aqueous solution of the fourth composition.
  • an aqueous solution is substantially corresponding to the second composition of the kit according to the present invention.
  • the aqueous solution is mixed with the first composition, e.g., referring to the way for mixing the first composition and the second composition of the kit according to the present invention.
  • the mask package 1 comprises:
  • a nonwoven fabric comprising from 0.01%to 5%by weight, preferably from 0.02%to 1%by weight, or preferably from 0.04%to 0.5%, of calcium sulphate or calcium carbonate, and from 0.001%to 1%by weight, especially from 0.01%to 0.1%by weight, such as 0.01%to 0.06%, of HEC or HPC, relative to the total weight of the nonwoven fabric, and
  • a fourth composition which is free of water, comprising from 0.1%to 0.5%by weight, preferably from 0.1%to 0.3%by weight, of the water soluble chelating agent and from 0.1%to 0.5%by weight, preferably from 0.2%to 0.4%by weight, of the water soluble gelatinizing agent, relative to the total weight of the composition,
  • weight ratio of the nonwoven fabric to the fourth composition ranges from 1: 3 to 1: 20, preferably from 1: 8 to 1: 15.
  • the first composition and the second/fourth composition according to the present invention can be generally prepared according to the general knowledge of a person skilled in the art. Nevertheless, it is to be understood that a person skilled in the art can choose the method of preparation, on the basis of his/her general knowledge, taking into account the nature of the constituents used, for example, their solubility in the vehicle, and the application envisaged for the compositions or the kit.
  • the kit according to the present invention can be used for caring for keratin materials, especially the face.
  • This use may manifest itself as a process for caring for keratin materials, especially the face, comprising the steps of compounding the first composition and the second composition of the kit at a predetermined weight ratio, and then applying to said keratin materials the thus obtained mixture as a mask.
  • the kit according to the present invention can be used for managing skin wound, for preventing post-surgical adhesion formation, or for filling or repairing osteochondral defects, and so on.
  • This use may manifest itself as a process for managing skin wound, for preventing post-surgical adhesion formation, or for filling or repairing osteochondral defects, comprising the steps of compounding the first composition and the second composition of the kit at a predetermined weight ratio, and then applying to a location in need of the thus obtained mixture as a mask or stuffing.
  • compositions/formulas described below are expressed in %by weight, relative to the total weight of each composition/formula.
  • the invention formulas A and B, and comparative formula A were prepared, as the second composition.
  • Protocol of preparation of the second composition using the formulas in table 1 all the ingredients were put into beaker, heated to 60°C and homogenized until uniform, cooled down to room temperature.
  • Protocol of preparation of masks 0.75g of each of the formulas A to B and comparative A, respectively, were placed together with a nonwoven fabric with a weight of 1.3g, made of 20%by weight of calcium alginate fiber and 80%of lyocell fiber, sold by the Sanjiang company under the name M762R-40CN.
  • the present invention and comparative masks were evaluated using the following protocols.
  • Evaluation process Apply the mask on face for 15 minutes and then take off and massage the skin. Perceive the greasiness of skin by moving finger pulp on the face. Then each panelist gave the score from 0 to 15. The less greasiness, the high score was given.
  • Evaluation index We graded from poor to excellent which was classified in the following 4 categories based on the scores: “excellent” (>12) , “good” (8-12) , “fair” (4-8) , “poor” (0-4) .
  • Evaluation process Apply the mask on face, and observe the quantity of bubbles around eye, nose and mouth. Then each panelist gave the score from 0 to 15. The less bubbles, the high score was given.
  • Evaluation index We graded from poor to excellent which was classified in the following 4 categories based on the scores: “excellent” (>12) , “good” (8-12) , “fair” (4-8) , “poor” (0-4) .
  • Evaluation process Apply the mask on face for 15 minutes and then take off and massage the skin. Observe the degree of lines on forehead and nasolabial folds, touch the cheek by index finger and middle figer and perceive the skin softness by tactile way, and observe the degree of fine lines on the cheek. Each panelist gave the score from 0 to 15. The more plumpy skin, the high score was given.
  • Evaluation Index We graded from poor to excellent which was classified in the following 4 categories based on the scores: “excellent” (>12) , “good” (8-12) , “fair” (4-8) , “poor” (0-4) .
  • Evaluation process Apply the mask on face for 15 minutes and then take off. Observe the quantity of juice left on skin by visual way. Then each panelist gave the score from 0 to 15. The more juice left on skin, the higher score was given.
  • Evaluation index We graded from poor to excellent which was classified in the following 4 categories based on the scores: “excellent” (>12) , “good” (8-12) , “fair” (4-8) , “poor” (0-4) .
  • Formula A Formula B Comparative Formula A Texture transformation Good Excellent poor Skin adhesion Excellent Excellent fair Fresh feel Excellent Fair good Hydration effect good Excellent fair Moisture delivery capacity excellent Fair poor
  • the mask of the present invention is superior in terms of beneficial properties, e.g. texture transformation, hydration effect and moisture delivery capacity, over the comparative one.
  • the invention formula C, and comparative formulas B-D were prepared, as the first composition.
  • Protocol of preparation of masks 0.75g of formula A was placed together with a nonwoven fabric with a weight of 1.3g, made of formula C and comparative formulas B-D, respectively, so as to provide mask C, and comparative masks B-D, respectively.
  • the present invention and comparative masks were evaluated using the following protocols.
  • Deformation (%) ( (value measured after fresh mix) - (initial value) ) / (initial value) .
  • the mask of the present invention is superior in terms of softness, over the comparative one.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Emergency Medicine (AREA)
  • Cosmetics (AREA)

Abstract

Kit comprenant : (1) une première composition comprenant au moins un sel insoluble dans l'eau de métal polyvalent et au moins un polymère polyhydroxy soluble dans l'eau, et (2) une seconde composition comprenant au moins une phase aqueuse, et a) au moins un agent chélatant soluble dans l'eau de l'ion métallique polyvalent, et b) au moins un agent gélifiant soluble dans l'eau, qui peut être gélatinisé par l'ion métallique polyvalent. Le kit peut être utilisé pour le soin de matières kératiniques, en particulier la peau, pour la gestion d'une plaie cutanée, pour la prévention de la formation d'adhérences post-chirurgicales ou pour le remplissage ou la réparation de défauts ostéochondraux.
PCT/CN2018/125363 2018-12-29 2018-12-29 Kit de soins de la peau WO2020133361A1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
CN202210758396.0A CN115192473B (zh) 2018-12-29 2018-12-29 用于护理皮肤的套装
PCT/CN2018/125363 WO2020133361A1 (fr) 2018-12-29 2018-12-29 Kit de soins de la peau
CN201880100560.0A CN113194908B (zh) 2018-12-29 2018-12-29 用于护理皮肤的套装

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2018/125363 WO2020133361A1 (fr) 2018-12-29 2018-12-29 Kit de soins de la peau

Publications (1)

Publication Number Publication Date
WO2020133361A1 true WO2020133361A1 (fr) 2020-07-02

Family

ID=71129544

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2018/125363 WO2020133361A1 (fr) 2018-12-29 2018-12-29 Kit de soins de la peau

Country Status (2)

Country Link
CN (2) CN113194908B (fr)
WO (1) WO2020133361A1 (fr)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022205059A1 (fr) * 2021-03-31 2022-10-06 L'oreal Compositions pour le soin de la peau et emballage pour les contenir
WO2022226872A1 (fr) * 2021-04-29 2022-11-03 L'oreal Trousse de soin de la peau
FR3126303A1 (fr) * 2021-08-25 2023-03-03 L'oreal Masque pour le soin des matières kératineuses
WO2023184315A1 (fr) * 2022-03-31 2023-10-05 L'oreal Kit pour le soin des matières kératiniques
WO2023184295A1 (fr) * 2022-03-31 2023-10-05 L'oreal Composition pour les soins des matières kératiniques

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102940583A (zh) * 2012-11-26 2013-02-27 中国工程物理研究院核物理与化学研究所 一种可作为营养面膜的温敏水凝胶及其制备方法
JP2016222612A (ja) * 2015-06-01 2016-12-28 昭和電工株式会社 化粧料または皮膚外用剤
JP2017052706A (ja) * 2015-09-07 2017-03-16 一丸ファルコス株式会社 顆粒を含有する化粧料組成物
TR201619953A2 (tr) * 2016-12-28 2018-07-23 Buelent Karaagac Topi̇kal terapöti̇k formülasyonlar

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8349301B2 (en) * 2002-06-04 2013-01-08 The Procter & Gamble Company Shampoo containing a gel network
US20060104931A1 (en) * 2004-11-12 2006-05-18 Takeshi Fukutome Cosmetic treatment article comprising substrate and gel composition
FR2940111B1 (fr) * 2008-12-19 2012-06-01 Oreal Kit de revetement des matieres keratiniques comprenant un polysaccharide et un agent de complexation ionique ou dative
FR3002448B1 (fr) * 2013-02-25 2015-04-03 Oreal Composition cosmetique de type gel
FR3025100B1 (fr) * 2014-08-28 2016-12-09 Oreal Composition cosmetique de type gel a tenue amelioree
FR3030231B1 (fr) * 2014-12-23 2018-08-24 L'oreal Utilisation d'un ester d'acide gras pour matifier la peau et composition comprenant cet ester

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102940583A (zh) * 2012-11-26 2013-02-27 中国工程物理研究院核物理与化学研究所 一种可作为营养面膜的温敏水凝胶及其制备方法
JP2016222612A (ja) * 2015-06-01 2016-12-28 昭和電工株式会社 化粧料または皮膚外用剤
JP2017052706A (ja) * 2015-09-07 2017-03-16 一丸ファルコス株式会社 顆粒を含有する化粧料組成物
TR201619953A2 (tr) * 2016-12-28 2018-07-23 Buelent Karaagac Topi̇kal terapöti̇k formülasyonlar

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022205059A1 (fr) * 2021-03-31 2022-10-06 L'oreal Compositions pour le soin de la peau et emballage pour les contenir
WO2022226872A1 (fr) * 2021-04-29 2022-11-03 L'oreal Trousse de soin de la peau
FR3122330A1 (fr) * 2021-04-29 2022-11-04 L'oreal Kit pour le soin de la peau
FR3126303A1 (fr) * 2021-08-25 2023-03-03 L'oreal Masque pour le soin des matières kératineuses
WO2023184315A1 (fr) * 2022-03-31 2023-10-05 L'oreal Kit pour le soin des matières kératiniques
WO2023184295A1 (fr) * 2022-03-31 2023-10-05 L'oreal Composition pour les soins des matières kératiniques

Also Published As

Publication number Publication date
CN115192473B (zh) 2024-06-11
CN113194908A (zh) 2021-07-30
CN113194908B (zh) 2024-01-16
CN115192473A (zh) 2022-10-18

Similar Documents

Publication Publication Date Title
WO2019047954A1 (fr) Kit de soin de la peau
WO2020001069A1 (fr) Kit de soins de la peau
CN115192473B (zh) 用于护理皮肤的套装
CN113194906B (zh) 用于皮肤护理的试剂盒
WO2020093206A1 (fr) Kit de soins de la peau
US11304881B2 (en) Composition based on an aqueous phase containing a dispersion of an anhydrous composite material
US20200138680A1 (en) Gel-type cosmetic composition
Kanlayavattanakul et al. Biopolysaccharides for skin hydrating cosmetics
WO2020181405A1 (fr) Trousse pour le soin de la peau
WO2020133308A1 (fr) Kit de soins de la peau
WO2019185915A1 (fr) Gel aqueux moussant comprenant un amidon modifié et un polysaccharide non amylacé
Gruber Polysaccharide-based polymers in cosmetics
WO2020258219A1 (fr) Kit de soin de la peau
WO2021217560A1 (fr) Trousse de soin de la peau
EP2945599B1 (fr) Composition cosmétique comprenant un polysaccharide spécifique, un polymère fixant anionique et un monoalcool ou polyol liquide, et méthode de coiffage la mettant en oeuvre
WO2021245081A1 (fr) Composition comprenant au moins trois types de polysaccharides, au moins un composé pâteux d'origine végétale et de l'eau
JP2024085649A (ja) 電解質及び多糖の組み合わせを含む組成物
WO2022123016A1 (fr) Substrat cosmétique d'origine naturelle
WO2019185913A1 (fr) Composition exfoliante anhydre comprenant des polyols en c3 à c10 et des polysaccharides
WO2024128168A1 (fr) Composition comprenant un électrolyte et une combinaison de polysaccharides
WO2023184295A1 (fr) Composition pour les soins des matières kératiniques
FR3023476A1 (fr) Composition solide aqueuse contenant un sel d'acide gras, un polyol et un gelifiant hydrophile
CN115768397A (zh) 包含短链脂肪酸盐的胶凝组合物
WO2022226872A1 (fr) Trousse de soin de la peau
Rinaudo BETWEEN THE MOLECULAR STRUCTURE, THE

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 18945053

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 18945053

Country of ref document: EP

Kind code of ref document: A1